EUCTR2005-003520-18-IT进行中（未招募）不适用
Multicenter, double-blind placebo controlled study of levetiracetam in the treatment of childhood and juvenile absence epilepsy.
ISTITUTO C. MONDINO0 个研究点目标入组 60 人开始时间: 2007年4月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Multi-center, double-blind, placebo-controlled study to investigate the efficacy and safety of daily oral 100 mg dehydroepiandrosterone (DHEA) over 6 treatment cycles as a concomitant therapy to oral contraceptives (OC) to alleviate complaints of reduced libido in women with acquired female sexual dysfunction (FSD) associated with OC-useEUCTR2006-004397-27-DEBayer Schering Pharma AG100
已完成
不适用
Multicenter, Randomized, Controlled Placebo Study measuring Effectiveness and Safety of TENOVIL (rHulL-10, SCH 52000) plus a Stable Dose of Methotrexate in Subjects with Active RHEUMATOID Arthritis.-M069M069PER-043-99SCHERING PLOUGH RESEARCH INSTITUTE,
已完成
2 期
Effects of low dose everolimus and/or BEZ235 on vaccine response in the elderlyACTRN12613001351707ovartis Institutes for BioMedical Research240
已完成
不适用
A double-blind placebo-controlled multicenter study to evaluate the efficacy and safety of MBP8298 in subjects with secondary progressive multiple sclerosis (SPMS)Nervous System DiseasesMultiple sclerosis (MS)Secondary Progressive Multiple SclerosisISRCTN98373474BioMS Technology Corp (Canada)553
尚未招募
2 期
Safety and efficacy trial of whey growth factor extract for oral mucositisOral mucositis in lymphoma patientsCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaACTRN12606000083594TGR Biosciences60